Results 181 to 190 of about 5,687 (195)

Acalabrutinib/ibrutinib

Reactions Weekly, 2022
openaire   +1 more source

Acalabrutinib/obinutuzumab

Reactions Weekly, 2021
openaire   +1 more source

Acalabrutinib Monotherapie (Erstlinie)

2021
Wörmann, Bernhard, Wendtner, Clemens, Stilgenbauer, Stephan, Schetelig, Johannes, Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie, Deutschland. Gemeinsamer Bundesausschuss   +5 more
openaire   +1 more source

The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic Leukemia

Clinical Cancer Research, 2017
Bonnie K Harrington, Carsten U Niemann, Fabienne McClanahan   +2 more
exaly  

Acalabrutinib/enoxaparin-sodium

Reactions Weekly, 2023
openaire   +1 more source

Acalabrutinib/Ibrutinib

Reactions Weekly
  +4 more sources

Acalabrutinib (Calquence®)

Oncology Times, 2018
openaire   +1 more source

Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile

Journal of Pharmacology and Experimental Therapeutics, 2017
exaly  

Acalabrutinib/zanubrutinib

Reactions Weekly
openaire   +1 more source

Acalabrutinib/prednisone

Reactions Weekly
openaire   +1 more source